TSE:KPT KP Tissue (KPT) Stock Price, News & Analysis C$8.09 -0.06 (-0.74%) As of 05/2/2025 03:40 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About KP Tissue Stock (TSE:KPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KP Tissue alerts:Sign Up Key Stats Today's RangeC$8.07▼C$8.1650-Day RangeC$7.71▼C$8.1752-Week RangeC$7.54▼C$8.65Volume12,534 shsAverage Volume13,702 shsMarket CapitalizationC$80.85 millionP/E Ratio12.67Dividend Yield8.90%Price TargetC$8.33Consensus RatingHold Company OverviewKP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.Read More… KP Tissue Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreKPT MarketRank™: KP Tissue scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingKP Tissue has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageKP Tissue has only been the subject of 2 research reports in the past 90 days.Read more about KP Tissue's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of KP Tissue is 12.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.97.Price to Earnings Ratio vs. SectorThe P/E ratio of KP Tissue is 12.67, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 11.16.Price to Earnings Growth RatioDue to a projected decrease in earnings for KP Tissue, their PEG ratio cannot be calculated.Price to Book Value per Share RatioKP Tissue has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for KPT. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipKP Tissue is a leading dividend payer. It pays a dividend yield of 9.15%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthKP Tissue does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of KP Tissue is 112.73%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about KP Tissue's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for KPT. News and Social Media2.3 / 5News SentimentN/A News SentimentKP Tissue has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.28 average news sentiment score of Consumer Defensive companies. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, KP Tissue insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.14% of the stock of KP Tissue is held by insiders.Percentage Held by InstitutionsOnly 8.61% of the stock of KP Tissue is held by institutions.Read more about KP Tissue's insider trading history. Receive KPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter. Email Address KPT Stock News HeadlinesInvest $25,000 in These Dividend Stocks to Combat Currency FluctationsApril 17, 2025 | msn.comA 9.2% Dividend Stock Paying Cash Every Single MonthApril 11, 2025 | msn.comAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.May 4, 2025 | Paradigm Press (Ad)Canadian companies must think twice before moving to the United StatesMarch 17, 2025 | theglobeandmail.comCIBC Reaffirms Their Hold Rating on KP Tissue (KPT)March 7, 2025 | markets.businessinsider.comKP Tissue reports fourth-quarter loss compared with a profit a year earlierMarch 5, 2025 | msn.comCould Trump tariffs cause COVID-19-like run on toilet paper? Leading Canadian producer thinks soFebruary 14, 2025 | theglobeandmail.com3 Canadian Dividend Stocks to Consider Adding to Your TFSA in 2025January 14, 2025 | msn.comSee More Headlines KPT Stock Analysis - Frequently Asked Questions How have KPT shares performed this year? KP Tissue's stock was trading at C$8.23 at the start of the year. Since then, KPT shares have decreased by 1.7% and is now trading at C$8.09. View the best growth stocks for 2025 here. How do I buy shares of KP Tissue? Shares of KPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of KP Tissue own? Based on aggregate information from My MarketBeat watchlists, some other companies that KP Tissue investors own include Constellation Software (CSU), Intact Financial (IFC), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Wheaton Precious Metals (WPM) and Vermilion Energy (VET). Industry, Sector and Symbol Stock ExchangeTSE SectorConsumer Defensive Industry Household & Personal Products Sub-IndustryN/A Current SymbolTSE:KPT CIKN/A Webkptissueinc.com Phone+1-905-8126900FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$8.33 High Stock Price TargetC$8.50 Low Stock Price TargetC$8.00 Potential Upside/Downside+3.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.64 Trailing P/E Ratio12.67 Forward P/E Ratio18.39 P/E Growth-0.88Net IncomeC$6.38 million Net MarginsN/A Pretax MarginN/A Return on Equity9.05% Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio1.23 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueC$7.08 per share Price / Book1.14Miscellaneous Outstanding Shares9,994,200Free FloatN/AMarket CapC$80.85 million OptionableNot Optionable Beta0.37 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (TSE:KPT) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KP Tissue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KP Tissue With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.